{"article_title": "HHS Asks DC Court To Nix PhRMA's 340B Orphan Drug Suit", "article_keywords": ["hhs", "340b", "court", "asks", "drugs", "orphan", "phrmas", "drug", "dc", "nix", "health", "rule", "suit", "department", "care"], "article_url": "http://www.law360.com/articles/615901/hhs-asks-dc-court-to-nix-phrma-s-340b-orphan-drug-suit", "article_text": "HHS Asks DC Court To Nix PhRMA's 340B Orphan Drug Suit\n\nLaw360, New York (January 28, 2015, 4:01 PM ET) -- The U.S. Department of Health and Human Services asked a D.C. federal court Tuesday to toss Pharmaceutical Research and Manufacturers of America's complaint challenging a department rule on discounting so-called orphan drugs in the 340B program, saying the interpretive rule wasn\u2019t subject to the court\u2019s review.\n\n\n\nHHS issued the rule in July, setting out the agency\u2019s reading of an Affordable Care Act provision that, in some health care settings, exempts drugs from the discount requirement if they\u2019re designated for a rare disease. HHS has threatened to severely...\n\nTo view the full article, register now.", "article_metadata": {"description": "The U.S. Department of Health and Human Services asked a D.C. federal court Tuesday to toss Pharmaceutical Research and Manufacturers of America&#39;s complaint challenging a department rule on discounting so-called orphan drugs in the 340B program, saying the interpretive rule wasn&rsquo;t subject to the court&rsquo;s review.", "apple-itunes-app": "app-id=934560389, app-argument=law360://www.law360.com/articles/615901/hhs-asks-dc-court-to-nix-phrma-s-340b-orphan-drug-suit", "csrf-token": "I8+oG00kcovOwhEdqIqBRv4AvBb6BS1iganPGemX8I845XbMyOqltQcA2Pb1zS9SDe5fM0tRJJhBARGPQjsSsQ==", "csrf-param": "authenticity_token", "og": {"url": "http://www.law360.com/articles/615901/hhs-asks-dc-court-to-nix-phrma-s-340b-orphan-drug-suit", "image": "https://www.law360.com/images/360.png", "type": "website", "title": "HHS Asks DC Court To Nix PhRMA's 340B Orphan Drug Suit  - Law360"}, "viewport": "width=device-width, initial-scale=1.0"}, "_id": "\"57477af36914bd0286fd26d7\"", "article_summary": "HHS Asks DC Court To Nix PhRMA's 340B Orphan Drug SuitLaw360, New York (January 28, 2015, 4:01 PM ET) -- The U.S. Department of Health and Human Services asked a D.C. federal court Tuesday to toss Pharmaceutical Research and Manufacturers of America's complaint challenging a department rule on discounting so-called orphan drugs in the 340B program, saying the interpretive rule wasn\u2019t subject to the court\u2019s review.\nHHS has threatened to severely...To view the full article, register now.\nHHS issued the rule in July, setting out the agency\u2019s reading of an Affordable Care Act provision that, in some health care settings, exempts drugs from the discount requirement if they\u2019re designated for a rare disease."}